Qorvo Biotechnologies, a semiconductor company that delivers radio frequency solutions that connect our smart devices, has just received FDA emergency use authorization for COVID-19 antigen testing through its new Omnia platform. The diagnostic tool uses high frequency, bulk acoustic wave sensors - technology that can be found in your home Wi-Fi networks - to detect COVID-19 antigens, providing accurate results in approximately 20 minutes.